Unlock stock picks and a broker-level newsfeed that powers Wall Street.
0.0346
-0.0013
(-3.62%)
At close: April 1 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
68
--
--
--
--
Operating Expense
16,080
14,210
11,609
4,449
6,453
Operating Income
-16,012
-14,210
-11,609
-4,449
-6,453
Net Non Operating Interest Income Expense
-614
-1,081
-630
-212
-3,308
Other Income Expense
-13,244
-10,941
50
64
6,494
Pretax Income
-29,870
-26,232
-12,189
-4,597
-3,267
Tax Provision
-2
--
1
-1
9
Net Income Common Stockholders
-29,868
-26,232
-12,190
-4,596
-3,276
Diluted NI Available to Com Stockholders
-29,868
-26,232
-12,190
-4,596
-3,276
Total Operating Income as Reported
-16,012
-14,210
-11,609
-4,449
-6,453
Total Expenses
16,080
14,210
11,609
4,449
6,453
Net Income from Continuing & Discontinued Operation
-29,868
-26,232
-12,190
-4,596
-3,276
Normalized Income
-16,622.8869
-15,140
-12,240
-4,569
-7,955.3000
Interest Expense
696
1,081
630
212
3,308
Net Interest Income
-614
-1,081
-630
-212
-3,308
EBIT
-29,174
-25,151
-11,559
-4,385
41
EBITDA
-29,174
-25,151
-11,559
-4,385
41
Net Income from Continuing Operation Net Minority Interest
-29,868
-26,232
-12,190
-4,596
-3,276
Total Unusual Items Excluding Goodwill
-13,246
-11,092
50
-27
6,410
Total Unusual Items
-13,246
-11,092
50
-27
6,410
Normalized EBITDA
-15,928
-14,059
-11,609
-4,358
-6,369
Tax Rate for Calcs
0
--
--
--
0.0003
Tax Effect of Unusual Items
-0.8869
--
--
--
1,730.7000
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NRSNW NeuroSense Therapeutics Ltd.
0.1751
-14.71%
CELUW Celularity Inc.
0.0410
+2.50%
SVA Sinovac Biotech Ltd.
6.47
0.00%
NBTX Nanobiotix S.A.
3.5800
+1.13%
COEP Coeptis Therapeutics Holdings, Inc.
9.47
+1.07%
LSB LakeShore Biopharma Co., Ltd
2.4000
-0.83%
OSRHW OSR Holdings, Inc.
0.0351
-12.25%
MAZE Maze Therapeutics, Inc.
9.90
-10.08%
RLFTF Relief Therapeutics Holding SA
2.6300
0.00%
DMAC DiaMedica Therapeutics Inc.
3.7500
-1.06%